Millennium Management’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-100,000
Closed -$850K 5927
2024
Q3
$850K Buy
+100,000
New +$589K ﹤0.01% 4401
2022
Q1
Sell
-54,600
Closed -$489K 6870
2021
Q4
$489K Buy
+54,600
New +$717K ﹤0.01% 5064

Millennium Management's APLT Position: Q1 2026 in Review

Millennium Management sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 1,051,846 shares — an estimated $105K sold.

Millennium Management first reported a position in APLT in Q2 2019 and held it in 24 quarters. The position peaked at $6.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

  • Millennium Management reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 1,051,846 Applied Therapeutics shares in Q1 2026, an estimated $105K.
  • Millennium Management first reported a position in Applied Therapeutics in Q2 2019 and held it in 24 quarters.
  • Millennium Management's Applied Therapeutics position peaked at $6.3M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.